Herceptin

Samsung Bioepis' First Cancer Biosimilar Approved by the FDA
BioSpace
Mon, 01/21/19 - 11:51 pm
FDA
Samsung Bioepis
Ontruzant
biosimilars
Genentech
Herceptin
FDA Approves 17th Biosimilar, Third for Herceptin
RAPS.org
Fri, 01/18/19 - 09:44 pm
FDA
Merck
Samsung Bioepis
Ontruzant
biosimilars
Roche
Herceptin
FDA approves Celltrion's Herceptin biosimilar
BioCentury
Sun, 12/16/18 - 12:23 am
FDA
Herceptin
biosimilars
Celltrion
HER2-positive metastatic breast cancer
7 drugs that raised eyebrows in Q3
Biopharma Dive
Thu, 11/15/18 - 11:50 pm
Sanofi
Dupixent
Roche
Herceptin
AbbVie
Humira
Regeneron
Repatha
Clovis Oncology
Rubraca
GSK
Shingrix
Eli Lilly
Trulicity
Can Kadcyla give Roche a softer landing when Herceptin biosims hit? New data could help
Fierce Pharma
Mon, 10/15/18 - 11:47 pm
Roche
Kadcyla
Herceptin
BRCA-mutant breast cancer
Pfizer Receives European Approval for Herceptin Biosimilar, Trazimera
CP Wire
Tue, 07/31/18 - 12:30 pm
Ttrazimera
Pfizer
biosimilars
Herceptin
Europe
Roche
Pfizer Receives European Approval for Herceptin Biosimilar, Trazimera
Tue, 07/31/18 - 12:29 pm
Pfizer
Trazimera
Herceptin
On top of expiring Herceptin patents, Roche faces huge royalty losses in 2019
Endpoints
Thu, 07/26/18 - 11:22 am
Roche
patents
Herceptin
Cabilly patents
Roche scrambles to boost Herceptin supply in China after insurance OK triggers shortage
Fierce Pharma
Wed, 06/6/18 - 09:33 am
Roche
Herceptin
China
FDA stalls yet another Herceptin copycat, issuing response letter to Amgen/Allergan
Endpoints
Fri, 06/1/18 - 10:40 pm
Amgen
Allergan
FDA
complete response letter
biosimilars
Herceptin
ABP 980
Pfizer Receives Good News for Trazimera (trastuzumab) Biosimilar
CP Wire
Fri, 06/1/18 - 10:10 am
Pfizer
CHMP
Europe
EMA
Trazimera
trastuzumab
biosimilars
Herceptin
Celltrion resubmits Rituxan candidate in US, Herceptin version to follow
Biopharma Reporter
Wed, 05/30/18 - 08:29 pm
Celltrion
Rituxan
biosimilars
FDA
Herceptin
Roche
Biogen
CT-P10
Mundipharma and Celltrion Heathcare Launch Herceptin Biosimilar Herzuma in Europe
CP Wire
Thu, 05/3/18 - 09:33 am
Herzuma
biosimilars
trastuzumab
Europe
Herceptin
Roche
Mundipharma
Celltrion
FDA Fails to Approve Pfizer's Biosimilar of Roche's Herceptin
CP Wire
Mon, 04/23/18 - 09:28 am
Pfizer
FDA
Roche
Herceptin
biosimilars
FDA Fails to Approve Pfizer's Biosimilar of Roche's Herceptin
Mon, 04/23/18 - 09:25 am
Pfizer
Herceptin
biosimilars
trastuzumab
Roche
Amgen and Allergan Hopeful that Herceptin Biosimilar Approval Will Be Around the Corner
Xtalks
Mon, 03/26/18 - 09:36 am
Amgen
Allergan
Herceptin
biosimilars
ABP 980
CHMP
EMA
Roche
AbbVie blockbuster leads 2017 top drug sales; Roche cancer meds follow closely
S&P Global
Wed, 03/14/18 - 09:38 pm
AbbVie
Roche
Humira
Rituxan
Herceptin
Avastin
Roche CEO Schwan concedes challenges as ‘highly, highly profitable’ drugs fall to biosimilar rivals
Fierce Pharma
Tue, 01/16/18 - 06:56 pm
Roche
Pharma CEOs
Severin Schwan
biosimilars
Herceptin
Rituxan
Avastin
The 2018 biosimilar litigation landscape: A primer
BioPharma Dive
Sun, 12/17/17 - 11:35 am
biosimilars
FDA
Neupogen
Neulasta
Remicade
Epogen
Enbreal
Humira
Avastin
Herceptin
Roche's Fight With Pfizer May Be Just The Beginning
Forbes
Mon, 12/11/17 - 11:31 pm
Roche
Pfizer
Herceptin
biosimilars
cancer
Avastin
Rituxan

Pages